Aquamantys(Tm)
Device Advanced Energy Hemostatic Device
PDI 00763000047412
General payments
$820,380
Research payments
$136,728
Through program year 2025, $820,380 in general payments and $136,728 in research payments were reported against Aquamantys(Tm) (Advanced Energy Hemostatic Device).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $85,680 | 900 |
| 2024 | General | $118,391 | 610 |
| 2024 | Research | $15,033 | 2 |
| 2023 | General | $259,185 | 1,039 |
| 2023 | Research | $120,395 | 4 |
| 2022 | General | $357,124 | 874 |
| 2022 | Research | $1,300 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 46 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 42 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
3,423 general · 7 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.